New Treatments vs Screening in Reducing Breast Cancer Deaths New Treatments vs Screening in Reducing Breast Cancer Deaths
Improvements in breast cancer screening and novel treatments have contributed to breast cancer mortality reductions in recent years, although the impact varies by disease subtype, say US scientists.Medscape Medical News
Immediate breast reconstruction after mastectomy for breast cancer does not delay initiation of adjuvant therapy, according to results from the iBRA-2 study.Reuters Health Information
The goal of the program is to screen underserved women in Syracuse for breast cancer.
ConclusionsWe provided further evidences for implication of miR-100 and mTOR pathway in breast cancer pathogenesis.
This study aimed to explore the prevalence of the use of complementary and alternative medicine (CAM) before diagnosis and during oncology therapy, and reveal the disclosure of CAM use among Hungarian breast cancer patients. MATERIALS AND METHODS: In a cross-sectional survey a self-administered questionnaire was used covering patients' demographics, oncology-related variables and various aspects of CAM use. Data were collected from 135 patients. Data analysis included descriptive analysis and Chi-square tests. RESULTS: The prevalence of CAM use was 52.6% before diagnosis while it was 84.4% during therapy. The mos...
CONCLUSIONS: There is contradictory evidence for the use of aloe vera in the setting of radiation in regards to its efficacy in the prevention and treatment of radiation-induced adverse effects. PMID: 31003648 [PubMed - in process]
Condition: Breast Cancer Interventions: Drug: Pyrotinib; Drug: Etoposide Sponsor: Chinese Academy of Medical Sciences Recruiting
Condition: Breast Cancer Interventions: Drug: Pyrotinib; Drug: capecitabine Sponsor: Chinese Academy of Medical Sciences Recruiting
This article examines how one woman's breast cancer battle illustrates the impact of structural racism: the convergence of social, cultural, economic and institutional forces to perpetuate racial group inequity.
A study of genetic testing in ovarian and breast cancer patients found substantial disparities in testing rates for ovarian cancer patients.
Publication date: Available online 20 April 2019Source: Inorganica Chimica ActaAuthor(s): Dhrubajyoti Majumdar, Sourav Das, Renjith Thomas, Zakir Ullah, S.S. Sreejith, Dhiraj Das, Pooja Shukla, Kalipada Bankura, Dipankar MishraAbstractTwo new dicyanamide modulated zinc metal complexes [Zn4(LOMe)2(µ1-dca)2(µ1,5-dca)2] (1) and [Zn3(LOEt)2(H2O)(µ1-dca)(µ1,5-dca)](2) have been synthesized using H2vanen-type compartmental ligands. Schiff base ligands and the complexes were characterized by means of elemental analyses, FT-IR, FT-Raman, UV-Visible, powder X-ray diffraction, TGA and fluorescence spectroscop...